[
  {
    "ts": "2026-01-28T12:48:58+00:00",
    "headline": "CMS selects next batch of 15 high-cost medicines for third negotiation cycle",
    "summary": "The 15 drugs accounted for $27bn in spending via Medicare Part B and Part D between November 2024 and October 2025.",
    "url": "https://www.pharmaceutical-technology.com/news/cms-selects-next-batch-of-15-high-cost-medicines-for-third-negotiation-cycle/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "62d39b3a-c971-3378-8437-69454e7eb072",
      "content": {
        "id": "62d39b3a-c971-3378-8437-69454e7eb072",
        "contentType": "STORY",
        "title": "CMS selects next batch of 15 high-cost medicines for third negotiation cycle",
        "description": "",
        "summary": "The 15 drugs accounted for $27bn in spending via Medicare Part B and Part D between November 2024 and October 2025.",
        "pubDate": "2026-01-28T12:48:58Z",
        "displayTime": "2026-01-28T12:48:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/64d2b01b91342b8aa8832daffb3a852f",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/C1nJneUQiExdSmoCae_JSg--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/64d2b01b91342b8aa8832daffb3a852f.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/63PlXOZomCP8u1XunFvtlg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/64d2b01b91342b8aa8832daffb3a852f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/cms-selects-next-batch-of-15-high-cost-medicines-for-third-negotiation-cycle/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cms-selects-next-batch-15-124858672.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVS"
            },
            {
              "symbol": "TAK"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "RHHBF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-28T14:00:00+00:00",
    "headline": "Connecticut Innovations Banks $41.0 Million in Venture Proceeds in Q2 FY26",
    "summary": "Connecticut Innovations (CI), Connecticut's strategic venture capital arm, today announced that it invested approximately $16.2 million in 23 companies and venture funds during the second quarter of its fiscal year, ending December 31, 2025. CI's investments leveraged $253.2 million in outside capital and generated $41 million in proceeds during the quarter. To date in fiscal year 2026, CI has invested $27.5 million and leveraged $340.1 million.",
    "url": "https://finance.yahoo.com/news/connecticut-innovations-banks-41-0-140000145.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "b8429d27-5763-3c45-a37a-93a12120c7db",
      "content": {
        "id": "b8429d27-5763-3c45-a37a-93a12120c7db",
        "contentType": "STORY",
        "title": "Connecticut Innovations Banks $41.0 Million in Venture Proceeds in Q2 FY26",
        "description": "",
        "summary": "Connecticut Innovations (CI), Connecticut's strategic venture capital arm, today announced that it invested approximately $16.2 million in 23 companies and venture funds during the second quarter of its fiscal year, ending December 31, 2025. CI's investments leveraged $253.2 million in outside capital and generated $41 million in proceeds during the quarter. To date in fiscal year 2026, CI has invested $27.5 million and leveraged $340.1 million.",
        "pubDate": "2026-01-28T14:00:00Z",
        "displayTime": "2026-01-28T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/d1adef6e396785b39a6086b40c80b99a",
          "originalWidth": 400,
          "originalHeight": 225,
          "caption": "Connecticut Innovations",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.TH96Cr90cGynw2SEOUEsQ--~B/aD0yMjU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/d1adef6e396785b39a6086b40c80b99a.cf.webp",
              "width": 400,
              "height": 225,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/h1VA6WKb1qR5bYtTSDMZaA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/d1adef6e396785b39a6086b40c80b99a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/connecticut-innovations-banks-41-0-140000145.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/connecticut-innovations-banks-41-0-140000145.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-28T15:21:56+00:00",
    "headline": "Texas Instruments, Circle, Johnson & Johnson: Top Analyst Calls",
    "summary": "Yahoo Finance Senior Reporter Brooke DiPalma keeps track of several Wall Street analyst calls on top trending stocks, including calls around shares of Texas Instruments (TXN), Circle Internet Group (CRCL), and Johnson & Johnson (JNJ).To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Catalysts.",
    "url": "https://finance.yahoo.com/video/texas-instruments-circle-johnson--johnson-top-analyst-calls-152156535.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "6c409c29-4949-43d5-831c-c11f941a5b14",
      "content": {
        "id": "6c409c29-4949-43d5-831c-c11f941a5b14",
        "contentType": "VIDEO",
        "title": "Texas Instruments, Circle, Johnson & Johnson: Top Analyst Calls",
        "description": "<p>Yahoo Finance Senior Reporter <a target=\"_blank\" rel=\"\" class=\"link\" href=\"https://www.yahoo.com/author/brooke-dipalma/\" data-i13n=\"slk:Brooke DiPalma;cpos:1;pos:1\">Brooke DiPalma</a> keeps track of several Wall Street analyst calls on top trending stocks, including calls around shares of Texas Instruments (<a target=\"_blank\" rel=\"\" class=\"link\" href=\"https://finance.yahoo.com/quote/TXN/\" data-i13n=\"slk:TXN;cpos:2;pos:1\">TXN</a>), Circle Internet Group (<a target=\"_blank\" rel=\"\" class=\"link\" href=\"https://finance.yahoo.com/quote/CRCL/\" data-i13n=\"slk:CRCL;cpos:3;pos:1\">CRCL</a>), and Johnson & Johnson (<a target=\"_blank\" rel=\"\" class=\"link\" href=\"https://finance.yahoo.com/quote/JNJ/\" data-i13n=\"slk:JNJ;cpos:4;pos:1\">JNJ</a>).</p><p>To watch more expert insights and analysis on the latest market action, check out moreÂ <a target=\"_blank\" rel=\"\" class=\"link\" href=\"https://finance.yahoo.com/videos/series/market-catalysts/\" data-i13n=\"slk:Market Catalysts;cpos:5;pos:1\">Market Catalysts</a>.</p>",
        "summary": "Yahoo Finance Senior Reporter Brooke DiPalma keeps track of several Wall Street analyst calls on top trending stocks, including calls around shares of Texas Instruments (TXN), Circle Internet Group (CRCL), and Johnson & Johnson (JNJ).To watch more expert insights and analysis on the latest market action, check out more&nbsp;Market Catalysts.",
        "pubDate": "2026-01-28T15:21:56Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2025-10/4568b570-af2b-11f0-b6b9-7f54a55fbb27",
          "originalWidth": 3000,
          "originalHeight": 2001,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2RdQbzhwmBdfiHgq3Vg7wA--~B/aD0yMDAxO3c9MzAwMDthcHBpZD15dGFjaHlvbg--/https://media-mbst-pub-ue1.s3.amazonaws.com/creatr-uploaded-images/2025-10/4568b570-af2b-11f0-b6b9-7f54a55fbb27.cf.webp",
              "width": 3000,
              "height": 2001,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UgjCWkpUG0UE2_FCtLh8Rw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media-mbst-pub-ue1.s3.amazonaws.com/creatr-uploaded-images/2025-10/4568b570-af2b-11f0-b6b9-7f54a55fbb27.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/texas-instruments-circle-johnson--johnson-top-analyst-calls-152156535.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/texas-instruments-circle-johnson--johnson-top-analyst-calls-152156535.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRCL"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "TXN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-28T14:50:00+00:00",
    "headline": "Diaper Market Forecast and Company Analysis Report 2025-2033 Featuring Kao, Kimberly-Clark, P&G, SCA, Unicharm, Cott, Pigeon, Johnson & Johnson, Hengan International",
    "summary": "The global diaper market is set to grow from $94.68 billion in 2025 to $160.63 billion by 2033, showcasing a CAGR of 6.83%. Rising birth rates in emerging markets and increasing demand for incontinence care drive growth in both baby and adult diaper segments. Urbanization, higher disposable incomes, and awareness of hygiene standards fuel consumer preference for convenient and high-quality diapers. Sustainability trends are pushing demand for eco-friendly products. The U.S., Germany, China, and",
    "url": "https://finance.yahoo.com/news/diaper-market-forecast-company-analysis-145000141.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "66d6b28b-30bd-33db-9b43-5edf07e9ede5",
      "content": {
        "id": "66d6b28b-30bd-33db-9b43-5edf07e9ede5",
        "contentType": "STORY",
        "title": "Diaper Market Forecast and Company Analysis Report 2025-2033 Featuring Kao, Kimberly-Clark, P&G, SCA, Unicharm, Cott, Pigeon, Johnson & Johnson, Hengan International",
        "description": "",
        "summary": "The global diaper market is set to grow from $94.68 billion in 2025 to $160.63 billion by 2033, showcasing a CAGR of 6.83%. Rising birth rates in emerging markets and increasing demand for incontinence care drive growth in both baby and adult diaper segments. Urbanization, higher disposable incomes, and awareness of hygiene standards fuel consumer preference for convenient and high-quality diapers. Sustainability trends are pushing demand for eco-friendly products. The U.S., Germany, China, and",
        "pubDate": "2026-01-28T14:50:00Z",
        "displayTime": "2026-01-28T14:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/f8be9b8dd90527c1bd694919bfd0f014",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Diaper Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/33QmNvKIBzdrP5_I.6KMIQ--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/f8be9b8dd90527c1bd694919bfd0f014.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RkpDTWXves9GsRMB.iVuMg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/f8be9b8dd90527c1bd694919bfd0f014.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/diaper-market-forecast-company-analysis-145000141.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/diaper-market-forecast-company-analysis-145000141.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KMB"
            },
            {
              "symbol": "PG"
            },
            {
              "symbol": "UNCHF"
            },
            {
              "symbol": "PGENY"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-28T14:39:13+00:00",
    "headline": "PayPal downgraded, UPS upgraded: Wall Street's top analyst calls",
    "summary": "PayPal downgraded, UPS upgraded: Wall Street's top analyst calls",
    "url": "https://finance.yahoo.com/news/paypal-downgraded-ups-upgraded-wall-143913385.html",
    "source": "The Fly",
    "provider": "yfinance",
    "raw": {
      "id": "144cfdeb-27ec-3534-9ddc-54227983b923",
      "content": {
        "id": "144cfdeb-27ec-3534-9ddc-54227983b923",
        "contentType": "STORY",
        "title": "PayPal downgraded, UPS upgraded: Wall Street's top analyst calls",
        "description": "",
        "summary": "PayPal downgraded, UPS upgraded: Wall Street's top analyst calls",
        "pubDate": "2026-01-28T14:39:13Z",
        "displayTime": "2026-01-28T14:39:13Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec",
          "originalWidth": 1200,
          "originalHeight": 628,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YHTvjvqtNAYBPYViMXYCow--~B/aD02Mjg7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec.cf.webp",
              "width": 1200,
              "height": 628,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J3gfZRz3Jb2im4_aLYVn4g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/the_fly_169/5039a5ccc6ec98e1b92bc672330bfcec.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Fly",
          "url": "https://thefly.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/paypal-downgraded-ups-upgraded-wall-143913385.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/paypal-downgraded-ups-upgraded-wall-143913385.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PYPL"
            },
            {
              "symbol": "BJ"
            },
            {
              "symbol": "COIN"
            },
            {
              "symbol": "AL"
            },
            {
              "symbol": "MCHPP"
            },
            {
              "symbol": "UPS"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "TXN"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BE"
            },
            {
              "symbol": "CLS"
            },
            {
              "symbol": "TPG"
            },
            {
              "symbol": "ROP"
            },
            {
              "symbol": "HTFL"
            },
            {
              "symbol": "MCHP"
            },
            {
              "symbol": "V"
            },
            {
              "symbol": "NUE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-28T15:15:00+00:00",
    "headline": "Merck's Non-Oncology Drugs Q4 Performance: What to Expect",
    "summary": "MRK's focus shifts beyond Keytruda in Q4 as investors watch new products Capvaxive and Winrevair, as well as Animal Health business sales performance.",
    "url": "https://finance.yahoo.com/news/mercks-non-oncology-drugs-q4-151500094.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "d794c769-6caa-3176-aa3a-81e4628fec1c",
      "content": {
        "id": "d794c769-6caa-3176-aa3a-81e4628fec1c",
        "contentType": "STORY",
        "title": "Merck's Non-Oncology Drugs Q4 Performance: What to Expect",
        "description": "",
        "summary": "MRK's focus shifts beyond Keytruda in Q4 as investors watch new products Capvaxive and Winrevair, as well as Animal Health business sales performance.",
        "pubDate": "2026-01-28T15:15:00Z",
        "displayTime": "2026-01-28T15:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/1b28b8f55ab25205feceb1a2771a2b3a",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RRg0vYpNavphT7S8O9jT7w--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1b28b8f55ab25205feceb1a2771a2b3a.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hIkvgr9e5vaptAEV_vkcVg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/1b28b8f55ab25205feceb1a2771a2b3a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mercks-non-oncology-drugs-q4-151500094.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mercks-non-oncology-drugs-q4-151500094.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]